Heart disease remains the leading cause of mortality worldwide, and many factors prevent clinicians from accurately predicting who is at risk of a heart attack. 

Professor Karlheinz Peter may have the solution that could save many lives.  

In this episode of Med Tech Talks, Robert Klupacs talks to internationally renowned interventional cardiologist Professor Karlheinz Peter, Deputy Director of the Baker Institute at the Alfred Hospital; and Chief Medical Officer at med tech company, Nirtek. 

Professor Peter and the team at Nirtek are developing intracoronary guidewire technology that can provide cardiologists with critical preventative health information. 

When steered into the arteries of the heart, their device aims to use near infrared light to identify dangerous, rupture-prone plaques before they lead to heart attacks. 

In this episode, you will hear about:  

• Professor Peter’s research into “intelligent drugs” and interventional cardiology that has spanned over 30 years.  
• How his team once foresaw an international pharmaceutical disaster 
• His insights into where further investment is needed in order to increase innovation in Australia 
• His learnings as a medical specialist, academic, researcher and entrepreneur

More information: 

Learn more about Professor Karlheinz Peter 

Find out more about Nirtek 

Read some publications from Professor Peter 

Updated version 05/08/22